Refresh
Exchange Announcement • 06 Mar 2024 20:55
Exchange Announcement • 06 Mar 2024 20:39
Exchange Announcement • 08 Feb 2024 08:15
Exchange Announcement • 08 Feb 2024 08:10
Exchange Announcement • 08 Feb 2024 08:05
ENTITY
Wave Life Sciences (WVE US)
Wave Life Sciences (WVE US)
11
Analysis
Health Care • United States
WaVe Life Sciences Ltd. operates as a pre-clinical biopharmaceutical company. The Company focuses on utilizing its proprietary synthetic chemistry drug development platform to design, develop, and commercialize stereopure nucleic acid therapeutics. WaVe Life Sciences develops disease-modifying drugs for indications with a high degree of unmet medical need in orphan.
more
x